Current Status and Future Direction of Community-based Management of Hypertension in China

Affiliations

Editorial

Yingxian Sun et al. J Transl Int Med. 2021.

. 2021 Jul 9;9(2):61-64.

doi: 10.2478/jtim-2021-0022. eCollection 2021 Jun.

¹ Department of Cardiology, The First Hospital of China Medical University, Shenyang110001, Liaoning Province, China.

No abstract available

Conflict of interest statement

Conflict of Interest None declared.

1. Wang Z, Chen Z, Zhang L, Wang X, Hao G, Zhang Z. et al. Status of Hypertension in China: Results From the China Hypertension Survey, 2012–2015. Circulation. 2018;137:2344–56. - PubMed
1. Zhou M, Wang H, Zeng X, Yin P, Zhu J, Chen W. et al. Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet (London, England) 2019;394:1145–58. - PMC - PubMed
1. 2018 Chinese Guidelines for Prevention and Treatment of Hypertension-A report of the Revision Committee of Chinese Guidelines for Prevention and Treatment of Hypertension. J Geriatr Cardiol. 2019;16:182–241. - PMC - PubMed
1. Li J, Shi L, Li S, Xu L, Qin W, Wang H. Urban-rural disparities in hypertension prevalence, detection, and medication use among Chinese Adults from 1993 to 2011. Int J Equity Health. 2017;16:50. - PMC - PubMed
1. Guidelines for the Prevention and Treatment of Hypertension in China (2018 Revision) Chin J Cardiol. 2019;24:24–56.